Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

European Society Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for Diagnosing Coeliac Disease 2020

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Impact of Metronidazole Treatment and Dientamoeba Fragilis Colonization on gut Microbiota Diversity

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Safety of High-Volume Plasmapheresis in Children With Acute Liver Failure

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Integration of eHealth Into Pediatric Inflammatory Bowel Disease Care is Safe: 3 Years of Follow-up of Daily Care

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Outcomes Following Pouch Formation in Paediatric Ulcerative Colitis: A Study from the Porto Group of ESPGHAN

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Extraintestinal Manifestations are Associated with Disease Severity in Pediatric Onset Inflammatory Bowel Disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Steffen Husby
  • Sibylle Koletzko
  • Ilma Korponay-Szabó
  • Kalle Kurppa
  • M Luisa Mearin
  • Carmen Ribes-Koninckx
  • Raanan Shamir
  • Riccardo Troncone
  • Renata Auricchio
  • Gemma Castillejo
  • Robin Christensen
  • Jernej Dolinsek
  • Peter Gillett
  • Asbjørn Hróbjartsson
  • Tunde Koltai
  • Markku Maki
  • Sabrina Mai Nielsen
  • Alina Popp
  • Ketil Størdal
  • Katharina Werkstetter
  • Margreet Wessels
Vis graf over relationer

OBJECTIVES: The ESPGHAN 2012 coeliac disease (CD) diagnostic guidelines aimed to guide physicians in accurately diagnosing CD and permit omission of duodenal biopsies in selected cases. Here, an updated and expanded evidence-based guideline is presented.

METHODS: Literature databases and other sources of information were searched for studies that could inform on 10 formulated questions on symptoms, serology, HLA genetics, and histopathology. Eligible articles were assessed using QUADAS2. GRADE provided a basis for statements and recommendations.

RESULTS: Various symptoms are suggested for case finding, with limited contribution to diagnostic accuracy. If CD is suspected, measurement of total serum IgA and IgA-antibodies against transglutaminase 2 (TGA-IgA) is superior to other combinations. We recommend against deamidated gliadin peptide antibodies (DGP-IgG/IgA) for initial testing. Only if total IgA is low/undetectable, an IgG-based test is indicated. Patients with positive results should be referred to a paediatric gastroenterologist/specialist. If TGA-IgA is ≥10 times the upper limit of normal (10× ULN) and the family agrees, the no-biopsy diagnosis may be applied, provided endomysial antibodies (EMA-IgA) will test positive in a second blood sample. HLA DQ2-/DQ8 determination and symptoms are not obligatory criteria. In children with positive TGA-IgA <10× ULN at least 4 biopsies from the distal duodenum and at least 1 from the bulb should be taken. Discordant results between TGA-IgA and histopathology may require re-evaluation of biopsies. Patients with no/mild histological changes (Marsh 0/I) but confirmed autoimmunity (TGA-IgA/EMA-IgA+) should be followed closely.

CONCLUSIONS: CD diagnosis can be accurately established with or without duodenal biopsies if given recommendations are followed.

TidsskriftJournal of Pediatric Gastroenterology and Nutrition
Udgave nummer1
Sider (fra-til)141-156
Antal sider16
StatusUdgivet - jan. 2020

ID: 60007627